jueves, 18 de agosto de 2022

Applying the Non-inferiority Paradigm to Assess Exposure-Response and Dosing Comparisons Between Pediatric and Adult Patients | FDA

Applying the Non-inferiority Paradigm to Assess Exposure-Response and Dosing Comparisons Between Pediatric and Adult Patients | FDA

No hay comentarios: